Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Volumetric modulated arc therapy for treatment of solid tumors: current insights.

Macchia G, Deodato F, Cilla S, Cammelli S, Guido A, Ferioli M, Siepe G, Valentini V, Morganti AG, Ferrandina G.

Onco Targets Ther. 2017 Jul 26;10:3755-3772. doi: 10.2147/OTT.S113119. eCollection 2017. Review.

2.

Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.

Ferrandina G, Palluzzi E, Fanfani F, Gentileschi S, Valentini AL, Mattoli MV, Pennacchia I, Scambia G, Zannoni G.

World J Surg Oncol. 2016 Dec 3;14(1):300. Review.

3.

Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.

Perrone F, Baldassarre G, Indraccolo S, Signoriello S, Chiappetta G, Esposito F, Ferrandina G, Franco R, Mezzanzanica D, Sonego M, Zulato E, Zannoni GF, Canzonieri V, Scambia G, Sorio R, Savarese A, Breda E, Scollo P, Ferro A, Tamberi S, Febbraro A, Natale D, Di Maio M, Califano D, Scognamiglio G, Lorusso D, Canevari S, Losito S, Gallo C, Pignata S.

Oncotarget. 2016 Nov 8;7(45):72654-72661. doi: 10.18632/oncotarget.12056.

4.

Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment.

Ciucci A, Zannoni GF, Buttarelli M, Martinelli E, Mascilini F, Petrillo M, Ferrandina G, Scambia G, Gallo D.

Oncotarget. 2016 Oct 18;7(42):68033-68043. doi: 10.18632/oncotarget.10797.

5.

Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.

Macchia G, Deodato F, Cilla S, Legge F, Carone V, Chiantera V, Valentini V, Morganti AG, Ferrandina G.

Oncol Lett. 2016 May;11(5):3446-3450. Epub 2016 Mar 29.

6.

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

Sestito R, Cianfrocca R, Rosanò L, Tocci P, Semprucci E, Di Castro V, Caprara V, Ferrandina G, Sacconi A, Blandino G, Bagnato A.

Oncotarget. 2016 Jan 26;7(4):4009-23. doi: 10.18632/oncotarget.6546.

7.

Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.

Macchia G, Cilla S, Deodato F, Legge F, Di Stefano A, Chiantera V, Scambia G, Valentini V, Morganti AG, Ferrandina G.

Br J Radiol. 2015;88(1055):20150385. doi: 10.1259/bjr.20150385. Epub 2015 Sep 21.

8.

Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer.

Petrillo M, Zannoni GF, Martinelli E, Pedone Anchora L, Ferrandina G, Tropeano G, Fagotti A, Scambia G.

PLoS One. 2015 Sep 3;10(9):e0136654. doi: 10.1371/journal.pone.0136654. eCollection 2015.

9.

On the cutting edge of intensity modulated radiotherapy and simultaneous integrated boost (IMRT-SIB): The case of a patient with 8 brain metastases.

Ferro M, Cilla S, Macchia G, Deodato F, Pierro A, Digesu' C, Ferrandina G, Ciuffreda M, Sallustio G, Morganti AG.

Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):316-9. doi: 10.1016/j.rpor.2014.09.001. Epub 2014 Sep 23.

10.

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study.

Ferrandina G, Corrado G, Mascilini F, Malaguti P, Samaritani R, Distefano M, Masciullo V, Di Legge A, Savarese A, Scambia G.

BMC Cancer. 2014 Dec 13;14:947. doi: 10.1186/1471-2407-14-947.

11.

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence.

Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G.

Onco Targets Ther. 2014 Jul 12;7:1273-84. doi: 10.2147/OTT.S51550. eCollection 2014. Review.

12.

Dose-dense FEC followed by dose-dense ixabepilone as neoadjuvant treatment for breast cancer patients: a feasibility study.

Clavarezza M, Bordonaro R, Daniele B, Ferrandina G, Barni S, Turazza M, Coati F, De Matteis A, De Placido S, Cognetti F, Olmeo NA, Carrozza F, Bruzzi P, Del Mastro L; Gruppo Italiano Mammella.

Oncologist. 2013;18(8):924-5. doi: 10.1634/theoncologist.2013-0222. Epub 2013 Aug 12. Erratum in: Oncologist. 2013;18(10):1149.

13.

Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial.

Deodato F, Cilla S, Macchia G, Caravatta L, Mignogna S, Massaccesi M, Picardi V, Digesu C, Sallustio G, Bonomo P, Piermattei A, Ferrandina G, Scambia G, Valentini V, Cellini N, Morganti AG.

Oncol Lett. 2013 Jun;5(6):1889-1896. Epub 2013 Mar 29.

14.

Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.

Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, Anchora LP, Scambia G, Ferrandina G.

BMC Cancer. 2013 Mar 18;13:127. doi: 10.1186/1471-2407-13-127.

15.

MiR-200c and HuR in ovarian cancer.

Prislei S, Martinelli E, Mariani M, Raspaglio G, Sieber S, Ferrandina G, Shahabi S, Scambia G, Ferlini C.

BMC Cancer. 2013 Feb 8;13:72. doi: 10.1186/1471-2407-13-72.

16.

Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report.

Borriello M, Lucidi A, Carbone A, Iannone V, Ferrandina G.

Diagn Pathol. 2012 Sep 1;7:116.

17.

Adrenomedullin in ovarian cancer: foe in vitro and friend in vivo?

Baranello C, Mariani M, Andreoli M, Fanelli M, Martinelli E, Ferrandina G, Scambia G, Shahabi S, Ferlini C.

PLoS One. 2012;7(7):e40678. doi: 10.1371/journal.pone.0040678. Epub 2012 Jul 30.

18.

Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful?

Massaccesi M, Digesù C, Macchia G, Deodato F, Ciuffreda M, Cucci E, Caravatta L, Corrado G, Padula GD, De Vizia R, Cellini N, Valentini V, Sallustio G, Ferrandina G, Pacelli F, Morganti AG.

Br J Radiol. 2012 Sep;85(1017):e682-5. doi: 10.1259/bjr/16600336. Epub 2012 Feb 14.

19.

Vulvar squamous cell carcinoma with sarcoma-like stroma: a case report and review of the literature.

Petrillo M, Corrado G, Carbone A, Macchia G, Ferrandina G.

Diagn Pathol. 2011 Oct 1;6:95. doi: 10.1186/1746-1596-6-95. Review.

20.

Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients.

Legge F, Paglia A, D'Asta M, Fuoco G, Scambia G, Ferrandina G.

BMC Cancer. 2011 May 31;11:214. doi: 10.1186/1471-2407-11-214.

Supplemental Content

Loading ...
Support Center